Posttransplantation relapse of pediatric chronic myelomonocytic leukemia cured using donor lymphocyte infusion

Affiliations

¹ Department of Pediatric Oncology and Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe), Lyon, France.
² Department of Medicine, University Lyon I, Lyon, France.
³ Laboratory of Hematology, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
⁴ Department of Pathology, Centre de lutte contre le cancer Léon Bérard, Lyon, France.
⁵ Department of Biology, Centre Hospitalier Universitaire de Lille, Lille, France.

Comment

Antony Ceraulo et al. Pediatr Blood Cancer. 2018 Feb.

. 2018 Feb;65(2).

doi: 10.1002/pbc.26808. Epub 2017 Sep 12.

¹ Department of Pediatric Oncology and Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe), Lyon, France.
² Department of Medicine, University Lyon I, Lyon, France.
³ Laboratory of Hematology, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
⁴ Department of Pathology, Centre de lutte contre le cancer Léon Bérard, Lyon, France.
⁵ Department of Biology, Centre Hospitalier Universitaire de Lille, Lille, France.

No abstract available

Comment on

Chronic myelomonocytic leukemia (CMML) as a second malignancy following Ewing sarcoma.
Riaz A, Inoue S, Onwuzurike N. Riaz A, et al. Pediatr Blood Cancer. 2007 Dec;49(7):1058. doi: 10.1002/pbc.21170. Pediatr Blood Cancer. 2007. PMID: 17366532 No abstract available.